Category Ranking

98%

Total Visits

921

Avg Visit Duration

2 minutes

Citations

20

Article Abstract

Background: There are now clinically available automated MRI analysis software programs that compare brain volumes of patients to a normative sample and provide -score data for various brain regions. These programs have yet to be validated in primary progressive aphasia (PPA).

Objective: To address this gap in the literature, we examined Neuroreader -scores in PPA, relative to visual MRI assessment. We predicted that Neuroreader 1) would be more sensitive for detecting left > right atrophy in the cortical lobar regions in logopenic variant PPA clinical phenotype (lvPPA), and 2) would distinguish lvPPA ( = 11) from amnestic mild cognitive impairment (aMCI;  = 12).

Methods: lvPPA or aMCI patients who underwent MRI with Neuroreader were included in this study. Two neuroradiologists rated 10 regions. Neuroreader lobar cores for those 10 regions, as well as a hippocampal asymmetry metric, were included in analyses.

Results: Cohen's Kappa coefficients were significant in 10 of the 28 computations ( = 0.351 to 0.593, ≤0.029). Neuroradiologists agreed 0% of the time that left asymmetry was present across regions. No significant differences emerged between aMCI and lvPPA in Neuroreader -scores across left or right frontal, temporal, or parietal regions (s > 0.10). There were significantly lower scores in the left compared to right for the hippocampus, as well as parietal, occipital, and temporal cortices in lvPPA.

Conclusion: Overall, our results indicated moderate to low interrater reliability, and raters never agreed that left asymmetry was present. While lower -scores in the left hemisphere regions emerged in lvPPA, Neuroreader failed to differentiate lvPPA from aMCI.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC9484148PMC
http://dx.doi.org/10.3233/ADR-220036DOI Listing

Publication Analysis

Top Keywords

primary progressive
8
progressive aphasia
8
neuroreader -scores
8
lvppa amci
8
left asymmetry
8
lvppa neuroreader
8
-scores left
8
regions
7
neuroreader
6
lvppa
6

Similar Publications

Introduction: Cutaneous scalp metastases from breast carcinoma (CMBC) represent an uncommon manifestation of metastatic disease, with heterogeneous clinical presentations, including nodular or infiltrative lesions and scarring alopecia (alopecia neoplastica). The absence of standardized diagnostic criteria, particularly for alopecic phenotypes, poses challenges to early recognition of CMBC, which may represent either the first indication of neoplastic progression or a late recurrence.

Materials And Methods: We retrospectively analyzed a multicenter cohort of 15 patients with histologically confirmed CMBC.

View Article and Find Full Text PDF

Background: Risk stratification in posterior circulation ischemic stroke (PCIS) is challenging. Although the Posterior Circulation Ischemic Stroke Outcome Score (PCISOS) was developed to address this, its utility in minor PCIS and in identifying homogeneous populations for clinical trials or treatment-responsive subgroups remains uncertain.

Methods: CHANCE-2 (Clopidogrel in High-Risk Patients With Acute Non-disabling Cerebrovascular Events-II) was a multicenter, randomized trial that enrolled patients with minor stroke or high-risk transient ischemic attack who carried CYP2C19 loss-of-function alleles.

View Article and Find Full Text PDF

Osteoarthritis (OA) is a prevalent chronic disease, characterized by progressive joint degeneration and primarily affects older adults. OA leads to reduced functional abilities, a lower quality of life, and an increased mortality rate. Currently, effective treatment options for OA are lacking.

View Article and Find Full Text PDF

Introduction: Primary central nervous system vasculitis (primary CNS vasculitis) is a rare inflammatory disorder that affects small-to-medium-sized cerebral vessels, often leading to recurrent strokes. Diagnosis is vague due to non-specific neurological symptoms. Imaging findings, cerebrospinal fluid (CSF) analysis and exclusion of systemic vasculitis are essential for diagnosis.

View Article and Find Full Text PDF

Unraveling epigenetic drivers of immune evasion in gliomas: mechanisms and therapeutic implications.

Front Immunol

September 2025

Precision Pharmacy and Drug Development Center, Department of Pharmacy, Tangdu Hospital, Fourth Military Medical University, Xi'an, Shaanxi, China.

Gliomas are the most common primary malignant tumors of the central nervous system (CNS), and despite progress in molecular diagnostics and targeted therapies, their prognosis remains poor. In recent years, immunotherapy has emerged as a promising treatment modality in cancer therapy. However, the inevitable immune evasion by tumor cells is a key barrier affecting therapeutic efficacy.

View Article and Find Full Text PDF